TELA TELA Bio, Inc.
TELA Bio, Inc. (TELA) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.19 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -28.4% since its last earnings release on August 10, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About TELA Bio, Inc.
TELA Bio, Inc. is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy.
Sector
Healthcare
Industry
Medical Instruments/Supply